K. Yoshisue
Pharmacokinetics Research Laboratory
Tokushima Research Center
Taiho Pharmaceutical Co.
Ltd., Tokushima
Japan
Name/email consistency: high
- Effects of 5-fluorouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats. Yoshisue, K., Nagayama, S., Shindo, T., Kawaguchi, Y. J. Pharmacol. Exp. Ther. (2001)
- Pharmacokinetics and biological fate of 3-(2,2, 2-trimethylhydrazinium)propionate dihydrate (MET-88), a novel cardioprotective agent, in rats. Yoshisue, K., Yamamoto, Y., Yoshida, K., Saeki, M., Minami, Y., Esumi, Y., Kawaguchi, Y. Drug Metab. Dispos. (2000)
- Reduction of 5-fluorouracil (5-FU) gastrointestinal (GI) toxicity resulting from the protection of thymidylate synthase (TS) in GI tissue by repeated simultaneous administration of potassium oxonate (Oxo) in rats. Yoshisue, K., Hironaga, K., Yamaguchi, S., Yamamoto, A., Nagayama, S., Kawaguchi, Y. Cancer Chemother. Pharmacol. (2000)
- Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent (drug combination of tegafur, 5-chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats. Yoshisue, K., Masuda, H., Matsushima, E., Ikeda, K., Nagayama, S., Kawaguchi, Y. Drug Metab. Dispos. (2000)